Tachyon operates with a dedicated internal core development team and a world-class external network of expertise. We enlist the support of leading experts in their field, from pharmacology to manufacturing, and from science to clinical to work with us in a dynamic and fast-paced development environment. Tachyon selects from the best preclinical and clinical contract research organizations (CRO) and outstanding contract manufacturing organizations (CMO) to achieve one goal – advance our innovative programs with scientific rigor, speed and quality. This highly flexible and effective model allows us to achieve our mission to bring new cancer drugs to patients in need as fast as possible.